These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11469752)

  • 1. Synthesis and evaluation of asperlicin analogues as non-peptidal cholecystokinin-antagonists.
    Lattmann E; Billington DC; Poyner DR; Howitt SB; Offel M
    Drug Des Discov; 2001; 17(3):219-30. PubMed ID: 11469752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility.
    Bock MG; DiPardo RM; Rittle KE; Evans BE; Freidinger RM; Veber DF; Chang RS; Chen TB; Keegan ME; Lotti VJ
    J Med Chem; 1986 Oct; 29(10):1941-5. PubMed ID: 3761313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718.
    van der Bent A; Blommaert AG; Melman CT; IJzerman AP; van Wijngaarden I; Soudijn W
    J Med Chem; 1992 Mar; 35(6):1042-9. PubMed ID: 1552499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modelling of asperlicin derived cholecystokinin A receptor antagonists.
    Van der Bent A; Ter Laak AM; IJzerman AP; Soudijn W
    Eur J Pharmacol; 1992 Aug; 226(4):327-34. PubMed ID: 1397061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of substituted 3-anilino-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepine-2-ones and their evaluation as cholecystokinin-ligands.
    Offel M; Lattmann P; Singh H; Billington DC; Bunprakob Y; Sattayasai J; Lattmann E
    Arch Pharm (Weinheim); 2006 Apr; 339(4):163-73. PubMed ID: 16572480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonists.
    Henke BR; Aquino CJ; Birkemo LS; Croom DK; Dougherty RW; Ervin GN; Grizzle MK; Hirst GC; James MK; Johnson MF; Queen KL; Sherrill RG; Sugg EE; Suh EM; Szewczyk JW; Unwalla RJ; Yingling J; Willson TM
    J Med Chem; 1997 Aug; 40(17):2706-25. PubMed ID: 9276016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties.
    Goetz MA; Lopez M; Monaghan RL; Chang RS; Lotti VJ; Chen TB
    J Antibiot (Tokyo); 1985 Dec; 38(12):1633-7. PubMed ID: 3005212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationship of new 1,5-dialkyl-1,5-benzodiazepines as cholecystokinin-2 receptor antagonists.
    Roberts K; Ursini A; Barnaby R; Cassarà PG; Corsi M; Curotto G; Donati D; Feriani A; Finizia G; Marchioro C; Niccolai D; Oliosi B; Polinelli S; Ratti E; Reggiani A; Tedesco G; Tranquillini ME; Trist DG; van Amsterdam FT
    Bioorg Med Chem; 2011 Jul; 19(14):4257-73. PubMed ID: 21689940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From peptide to non-peptide. 3. Atropisomeric GPIIbIIIa antagonists containing the 3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione nucleus.
    Blackburn BK; Lee A; Baier M; Kohl B; Olivero AG; Matamoros R; Robarge KD; McDowell RS
    J Med Chem; 1997 Feb; 40(5):717-29. PubMed ID: 9057858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical synthesis of potential endothelin receptor antagonists of 1,4-benzodiazepine-2,5-dione derivatives bearing substituents at the C3-, N1- and N4-positions.
    Cheng MF; Yu HM; Ko BW; Chang Y; Chen MY; Ho TI; Tsai YM; Fang JM
    Org Biomol Chem; 2006 Feb; 4(3):510-8. PubMed ID: 16446809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Structure elucidation.
    Liesch JM; Hensens OD; Springer JP; Chang RS; Lotti VJ
    J Antibiot (Tokyo); 1985 Dec; 38(12):1638-41. PubMed ID: 3841533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial solid phase synthesis of multiply substituted 1,4-benzodiazepines and affinity studies on the CCK2 receptor (part 1).
    Lattmann E; Billington DC; Poyner DR; Arayarat P; Howitt SB; Lawrence S; Offel M
    Drug Des Discov; 2002; 18(1):9-21. PubMed ID: 12375632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on a novel, potent and orally effective cholecystokinin A antagonist, FK-480. Synthesis and structure-activity relationships of FK-480 and related compounds.
    Satoh Y; Matsuo T; Sogabe H; Itoh H; Tada T; Kinoshita T; Yoshida K; Takaya T
    Chem Pharm Bull (Tokyo); 1994 Oct; 42(10):2071-83. PubMed ID: 7805132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of N-terminal substituted anthranilic acid dimer derivatives for evaluation on CCK receptors.
    Varnavas A; Valenta V; Berti F; Lassiani L
    Farmaco; 2001 Aug; 56(8):555-64. PubMed ID: 11601640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists.
    Evans BE; Rittle KE; Bock MG; DiPardo RM; Freidinger RM; Whitter WL; Gould NP; Lundell GF; Homnick CF; Veber DF
    J Med Chem; 1987 Jul; 30(7):1229-39. PubMed ID: 2885419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and X-ray crystallographic analysis of quinazolinone cholecystokinin/gastrin receptor ligands.
    Yu MJ; McCowan JR; Mason NR; Deeter JB; Mendelsohn LG
    J Med Chem; 1992 Jul; 35(14):2534-42. PubMed ID: 1635055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted 1,4-benzodiazepin-2-amines.
    Bock MG; DiPardo RM; Evans BE; Rittle KE; Freidinger RM; Chang RS; Lotti VJ
    J Med Chem; 1988 Jan; 31(1):264-8. PubMed ID: 3336026
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and evaluation of N1-substituted-3-propyl-1,4-benzodiazepine-2-ones as cholecystokinin (CCK2) receptor ligands.
    Lattmann E; Sattayasai J; Billington DC; Poyner DR; Puapairoj P; Tiamkao S; Airarat W; Singh H; Offel M
    J Pharm Pharmacol; 2002 Jun; 54(6):827-34. PubMed ID: 12078999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: identification of the 1-(4-amino-3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent.
    Micale N; Colleoni S; Postorino G; Pellicanò A; Zappalà M; Lazzaro J; Diana V; Cagnotto A; Mennini T; Grasso S
    Bioorg Med Chem; 2008 Mar; 16(5):2200-11. PubMed ID: 18083036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis of potential CCK antagonist quinazolone derivatives].
    Szabó M; Kökösi J; Orfi L
    Acta Pharm Hung; 1995 Jul; 65(4):133-8. PubMed ID: 7572196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.